---
title: "ASCENDIS PHARMA UK LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/de9ec1df-8fd4-51ca-9cf2-092ce1ce6127
json: https://whiteintel.dev/api/public/dossier/de9ec1df-8fd4-51ca-9cf2-092ce1ce6127
identifier: oo:GB-COH-15170831
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ASCENDIS PHARMA UK LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-15170831`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/de9ec1df-8fd4-51ca-9cf2-092ce1ce6127  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/de9ec1df-8fd4-51ca-9cf2-092ce1ce6127  

## Company profile (live · UK Companies House)

- **Company number:** `15170831`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2023-09-28
- **Registered office:** 81-87 High Holborn, London, WC1V 6DF, England
- **SIC:** 46460

### Officers

- CARSTENSEN, Anders — director · Danish · appointed 2024-08-30
- NOYOLA, Nyssa Liebermann — director · American · appointed 2026-07-21
- WHITEHOUSE, Benjamin David — director · British · appointed 2024-08-30
- THOMSEN, Henrik Bolgan — director · Danish · appointed 2023-09-28 · resigned 2024-08-30
- WITH FOGSTRUP, Anders — director · Danish · appointed 2024-08-30 · resigned 2026-05-13

### Beneficial owners (Persons with Significant Control)

- Ascendis Pharma A/S — 75–100% shares · corporate PSC · Denmark — since 2023-09-28

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/15170831
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/15170831

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **ASCENDIS PHARMA UK LIMITED** — https://whiteintel.dev/entity/de9ec1df-8fd4-51ca-9cf2-092ce1ce6127 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ASCENDIS PHARMA UK LIMITED**. Human view: https://whiteintel.dev/entity/de9ec1df-8fd4-51ca-9cf2-092ce1ce6127 · Structured JSON: https://whiteintel.dev/api/public/dossier/de9ec1df-8fd4-51ca-9cf2-092ce1ce6127._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._